ING Groep NV lowered its stake in shares of Plains GP Holdings, L.P. (NYSE:PAGP – Free Report) by 25.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 232,000 shares of the pipeline company’s stock after selling 78,000 shares during the period. ING Groep NV owned approximately 0.12% of Plains GP worth $4,292,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Cetera Investment Advisers increased its position in Plains GP by 644.7% during the 1st quarter. Cetera Investment Advisers now owns 154,961 shares of the pipeline company’s stock worth $2,828,000 after purchasing an additional 134,153 shares in the last quarter. Janus Henderson Group PLC purchased a new position in shares of Plains GP in the 1st quarter valued at $1,669,000. Bahl & Gaynor Inc. lifted its holdings in shares of Plains GP by 82.7% during the 1st quarter. Bahl & Gaynor Inc. now owns 921,467 shares of the pipeline company’s stock valued at $16,817,000 after acquiring an additional 417,031 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in Plains GP during the 2nd quarter worth $566,000. Finally, CUSHING ASSET MANAGEMENT LP dba NXG INVESTMENT MANAGEMENT boosted its position in Plains GP by 1.2% during the 3rd quarter. CUSHING ASSET MANAGEMENT LP dba NXG INVESTMENT MANAGEMENT now owns 4,373,000 shares of the pipeline company’s stock worth $80,900,000 after purchasing an additional 53,000 shares during the period. Institutional investors and hedge funds own 88.30% of the company’s stock.
Plains GP Price Performance
PAGP stock opened at $18.23 on Friday. The company has a market capitalization of $3.60 billion, a PE ratio of 21.45 and a beta of 1.54. The company has a quick ratio of 0.90, a current ratio of 1.01 and a debt-to-equity ratio of 0.49. The stock’s 50 day moving average is $18.44 and its two-hundred day moving average is $18.56. Plains GP Holdings, L.P. has a 52-week low of $14.93 and a 52-week high of $20.10.
Plains GP Dividend Announcement
Analyst Ratings Changes
A number of research analysts have commented on PAGP shares. Morgan Stanley cut Plains GP from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $22.00 to $19.00 in a research note on Friday, October 25th. StockNews.com raised Plains GP from a “hold” rating to a “buy” rating in a research report on Friday, November 8th. Finally, Wolfe Research upgraded Plains GP to a “hold” rating in a report on Wednesday, September 18th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $19.88.
View Our Latest Research Report on Plains GP
Plains GP Company Profile
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.
Featured Stories
- Five stocks we like better than Plains GP
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top-Performing Non-Leveraged ETFs This Year
- Investing in Travel Stocks Benefits
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding PAGP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plains GP Holdings, L.P. (NYSE:PAGP – Free Report).
Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.